Altay Therapeutics

Ownership

Private

Employees

~6

Therapeutic Areas

GastroenterologyOncologyPulmonologyNeurology

Stage

Preclinical

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Modalities

Small molecules

Altay Therapeutics General Information

Promising preclinical efficacy across multiple indications using novel TF-targeting approach; no clinical data yet

Contact Information

Website

https://www.altaytherapeutics.com/

Primary Industry

Biotech

Corporate Office

San Carlos, CA
USA

Drug Pipeline

No pipeline data available

For full access to Altay Therapeutics's pipeline data

Key Partnerships

Funding from FSHD Global Foundation, NIH SBIR Phase I grants

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Altay Therapeutics Funding

No funding data available

Early Stage VC (Series A)	04-Jun-2020	$38M	Completed	Phase 1
Seed Round	12-Feb-2019	$8.5M	Completed	Startup

Interested in comprehensive profile data?

We'll help you find what you need

To view Altay Therapeutics's complete valuation and funding history, request access »

Altay Therapeutics Financial Metrics